Viewing Study NCT00274651

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:39 PM
Ignite Modification Date: 2026-04-09 @ 7:57 AM
Study NCT ID: NCT00274651
Status: TERMINATED
Last Update Posted: 2015-07-28
First Post: 2006-01-10
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Phase II Clinical Trial of PXD101 in Patients With Recurrent or Refractory Cutaneous and Peripheral T-Cell Lymphomas
Sponsor: Valerio Therapeutics
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cutaneous T-Cell Lymphoma View
None Peripheral T-Cell Lymphoma View
None Non-Hodgkin's Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CTCL View
None PTCL View
None lymphoma View
None Non-Hodgkin's Lymphoma View
None Cutaneous T-Cell Lymphomas (CTCL) View
None Peripheral T-Cell Lymphomas (PTCL) View
None Other Types of Non-Hodgkin's Lymphoma View
None belinostat View